| GTO ID | GTC2236 |
| Trial ID | NCT04156217 |
| Disease | Posttransplantation Lymphoproliferative Disease |
| Altered gene | EBV |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | EBV TCR-T cells |
| HLA | HLA-A*11:01|HLA-A*02:01|HLA-A*24:02 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Pilot Study of EBV-TCR-T Cells in EB Virus Infection Diseases After HSCT |
| Year | 2019 |
| Country | China |
| Company sponsor | Hebei Yanda Ludaopei Hospital |
| Other ID(s) | HXYT-004 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||